Ownmed Innovation’s technology provides an alternative to ostomy bags, allowing patients to have greater autonomy and control over waste disposal and improving their quality of life.
Read more
Adcendo ApS (“Adcendo”), a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) for the treatment of cancers with a high unmet medical need, today announces t...
Read more
A new paper finds now in animal models that when mTOR activity is just slightly increased, ageing set earlier on, and the lifetime of animals can be shortened by up to 20%.
Read more
Augustine Therapeutics, a pioneering biotech company focused on novel treatments for neurodegenerative and cardiometabolic diseases, today announced that it has raised EUR 17 million (USD 18.5 million...
Read more
Before carrying out any investment round, it is essential to first quantify the start-up/spin-off’s need for cash. Once the need for cash has been identified, one of the most critical aspects of thi...
Read more
Asabys Partners announced today the successful final close of its second fund, Sabadell Asabys Health Innovation Investments II (SAHII II) with total commitments of €180 million ($200M), exceeding i...
Read more
Bio & Tech Smart Capital FCRE, fondo de capital riesgo de Noso Capital, lidera la ronda de inversión abierta por ADNTRO Genetics que asciende a 1 millón de euros, para impulsar la expansión de N-GE...
Read more
The company will use this new capital to accelerate the clinical testing and market launch of its first product, HyperSperm, a revolutionary sperm-focused assisted reproduction technique.
Read more
This 2023 has been a great year in terms of funding received by the public research institutes, centres and groups at the Barcelona Science Park, which mobilised 69.9 million euros, of which 57.1 mill...
Read more
he round was led by imec.xpand with new investors EIC Fund, Fond ICO Next Tech, CDTI-Innvierte and Avançsa. Existing investors Asabys Partners, Aliath Bioventures and Vsquared also participated, brin...
Read more
Biointaxis, an academic spin-off from the Germans Trias i Pujol Research Institute (IGTP) founded in 2018, is developing the first drug designed to prevent and reverse the neurological and cardiac eff...
Read more
Laminar Pharma es una empresa biotecnológica española que está desarrollando su principal compuesto LAM561, un derivado sintético del ácido oleico que puede ingerirse por vía oral. Este fármaco...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Acute myeloid leukemia (AML) does more than infiltrate the lungs: it a...
